We are looking forward to meeting you at ASGCT!
Cellipont Bioservices is a cell therapy CDMO with more than 15 years’ experience in the development and small-to-large batch manufacturing of cell therapies.
Our leaders have played an instrumental role in shaping cell therapy development and manufacturing methods and technologies, and our technically-strong team has been recognized by customers and technology partners for its ability to productively grow challenging cells. Cellipont is driven to help our clients expand patient access to life-changing medicines through best-in-class development, analytical and manufacturing capabilities.
Cellipont services include the creation of master and working cell banks, analytical and process development, and manufacturing services for a range of clients from preclinical (research & development) to Phase I-II with near term Phase III to commercialization capabilities.